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Cell surface ﬂip-ﬂop of phosphatidylserine is
critical for PIEZO1-mediated myotube formation
Masaki Tsuchiya1, Yuji Hara 1,2, Masaki Okuda1, Karin Itoh1, Ryotaro Nishioka1, Akifumi Shiomi1,
Kohjiro Nagao1, Masayuki Mori1, Yasuo Mori1, Junichi Ikenouchi3, Ryo Suzuki4,13, Motomu Tanaka 4,5,13,
Tomohiko Ohwada6, Junken Aoki7, Motoi Kanagawa8, Tatsushi Toda9, Yosuke Nagata10, Ryoichi Matsuda 11,
Yasunori Takayama12, Makoto Tominaga12 & Masato Umeda 1
Myotube formation by fusion of myoblasts and subsequent elongation of the syncytia is
essential for skeletal muscle formation. However, molecules that regulate myotube formation
remain elusive. Here we identify PIEZO1, a mechanosensitive Ca2+ channel, as a key reg-
ulator of myotube formation. During myotube formation, phosphatidylserine, a phospholipid
that resides in the inner leaﬂet of the plasma membrane, is transiently exposed to cell surface
and promotes myoblast fusion. We show that cell surface phosphatidylserine inhibits PIEZO1
and that the inward translocation of phosphatidylserine, which is driven by the phospholipid
ﬂippase complex of ATP11A and CDC50A, is required for PIEZO1 activation. PIEZO1-
mediated Ca2+ inﬂux promotes RhoA/ROCK-mediated actomyosin assemblies at the lateral
cortex of myotubes, thus preventing uncontrolled fusion of myotubes and leading to polarized
elongation during myotube formation. These results suggest that cell surface ﬂip-ﬂop of
phosphatidylserine acts as a molecular switch for PIEZO1 activation that governs proper
morphogenesis during myotube formation.
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Transbilayer relocation of phospholipids at the plasmamembrane is critical for various cellular processes such ascell division, signal transduction, and vesicular transport1–
4. Phosphatidylserine (PS), a negatively charged phospholipid,
normally resides in the inner leaﬂet of the plasma membrane5.
Controlled cell surface exposure of PS acts as a potent promoter
of blood coagulation, apoptotic cell engulfment, and myogen-
esis6–9. Mammalian skeletal muscles are formed by the fusion of
mononucleated precursor cells (myoblasts) into unusually elon-
gated multinucleated cells called myotubes, whose formation
relies on orchestrated cell-to-cell fusion and elongation of mul-
tinucleated syncytia10, 11. During myotube formation, PS tran-
siently translocates to the outer leaﬂet of the plasma membrane
and recognition of cell surface-exposed PS by PS receptors
induces contact-dependent signaling to promote fusion with
neighboring myoblasts9, 12–15. However, it remains unclear how
the transbilayer relocation of PS at the plasma membrane is
controlled during myotube formation.
Several members of the type IV subfamily of P-type adenosine
triphosphatases (P4-ATPases) that are complexed with an aux-
iliary CDC50 subunit act as a phospholipid ﬂippase that trans-
locates the cell surface-exposed PS to the inner leaﬂet of the
plasma membrane3, 4, 8, 16–18. In mammals, at least 14 members
of P4-ATPases, designated ATP8A1 through ATP11C, and three
CDC50 family proteins (CDC50A, CDC50B, and CDC50C) have
been identiﬁed3, 4, 17, 18. ATP8A1, ATP8A2, ATP8B1, ATP8B2,
ATP8B4, ATP10A, ATP10D, ATP11A, and ATP11C are localized
to the plasma membrane, whereas ATP9A, ATP9B, ATP10B, and
ATP11B are distributed to intracellular membranes3, 4, 8, 16–18.
Among the cell surface-localized P4-ATPases, ATP8A1, ATPA2,
ATP8B1, ATP11A, and ATP11C have been shown to catalyze the
inward translocation of PS at the plasma membrane3, 4, 8, 16–18.
As ﬁrst reported in yeast4, 19, complex association with CDC50
family proteins is required for transport of these P4-ATPases
from endoplasmic reticulum to the plasma membrane, where
they play a dominant role in maintaining the asymmetric dis-
tribution of PS in the bilayer leaﬂet3, 4, 8, 16–18, 20.
Although little is known about the physiological functions of
mammalian P4-ATPases, deﬁciencies of at least three P4-ATPa-
ses, ATP8A2, ATP8B1, and ATP11C, can cause severe human
disease3, 17, 18, 21, 22. Mutations identiﬁed in ATP8A2, which is
highly expressed in the brain, testes, and retina, are associated
with cerebellar ataxia, mental retardation and disequilibrium
syndrome17, 18. Mutations in ATP8B1 cause liver disorders such
as progressive familial intrahepatic cholestasis type 1 (PFIC1) and
benign recurrent intrahepatic cholestasis type 1 (BRIC1)17. A
mutation in ATP11C is liked to a congenital hemolytic anemia22.
In vivo studies in mouse models have also contributed to our
understanding of the physiological functions of mammalian P4-
ATPases: Atp8a1-deﬁcient mice exhibit delayed hippocampus-
dependent learning, Atp8a2-mutant mice display neurological
abnormalities such as ataxia derived from axonal degeneration
and loss of visual/auditory functions, and Atp11c-mutant mice
show arrested B cell development17, 21. ATP11A is ubiquitously
expressed in various tissues16 and deletion of Atp11a results in
lethality during embryogenesis23. The function of P4-ATPases in
skeletal muscle, however, remains to be elucidated.
Here we identify the phospholipid ﬂippase complex of
ATP11A and CDC50A as a critical regulator for activation of the
mechanosensitive Ca2+ channel PIEZO124, 25 during myotube
formation. We show that the phospholipid ﬂippase-mediated
translocation of cell surface-exposed PS is a prerequisite for
activation of PIEZO1 and that PIEZO1-mediated Ca2+ inﬂux
promotes RhoA/ROCK-dependent actomyosin assemblies26, thus
leading to controlled cell fusion and the polarized elongation of
multinucleated myotubes. The inhibitory effect of cell surface-
exposed PS on PIEZO1 is strictly dependent on the headgroup
structure of PS, and is controlled by manipulating the amount of
PS present on the cell surface. Furthermore, the myoblast-speciﬁc
disruption of Atp11a results in the formation of abnormal myo-
ﬁbres that fuse with each other during muscle regeneration after
injury.
Results
ATP11A/CDC50A is required for myotube formation. In this
study, we detected the expression of seven genes encoding P4-
ATPases and a single gene for a CDC50 family protein, CDC50A,
in mouse C2C12 myoblasts12, 27 (Supplementary Figure 1a–c).
Under myogenic differentiation conditions as indicated by the
expression of muscle-type myosin heavy chain (MyHC), C2C12
myoblasts changed cell shape to a bipolar form and fused to
generate elongated multinucleated myotubes, thereby providing a
quantiﬁable in vitro model of myogenesis (Fig. 1a). CDC50A-
deﬁcient C2C12 cells produced by the CRISPR/Cas9 system28
(Supplementary Figure 1d) differentiated and fused with neigh-
boring cells, but formed aberrantly enlarged syncytia with an
undeﬁned cell shape (Fig. 1a). Nuclei number and aspect ratios of
the syncytia indicated excessive cell fusion and defects in polar-
ized elongation in the CDC50A-deﬁcient cells (Fig. 1b and Sup-
plementary Figure 1e). Among the P4-ATPases expressed in
C2C12 cells, ATP8B1, ATP8B2, ATP11A, ATP11B, and ATP11C
were found to associate with CDC50A (Supplementary Figure 1f).
We then established a series of P4-ATPase-deﬁcient cell lines
(Supplementary Figure 1d) and demonstrated that ATP11A-
deﬁcient cells formed enlarged syncytia with morphological fea-
tures similar to those of the CDC50A-deﬁcient cells (Fig. 1a, b
and Supplementary Figure 1e). Live-cell imaging showed that
neighboring C2C12 myoblasts fused with each other, and the
resulting syncytia elongated longitudinally to form mature myo-
tubes (Supplementary Figure 1g and Supplementary Movie 1). In
contrast, ATP11A-deﬁcient and CDC50A-deﬁcient cells exces-
sively fused with neighboring myoblasts, and the resulting syn-
cytia spread without polarized elongation, forming an enlarged
sheet-like morphology (Supplementary Figure 1g, Supplementary
Movies 2 and 3). These observations were further conﬁrmed
using human primary myoblasts in which the phospholipid
ﬂippase complex of ATP11A and CDC50A was also robustly
expressed (Supplementary Figure 2a). siRNA-mediated depletion
of either CDC50A or ATP11A caused similar morphological
abnormalities in syncytia without affecting differentiation
(Fig. 1c, d and Supplementary Figure 2b, c). Retrovirus-mediated
gene transfer was conducted to conﬁrm the role of the phos-
pohlipid ﬂippase complex in myotube formation. Morphological
abnormalities in the CDC50A-deﬁcient or ATP11A-deﬁcient
C2C12 syncytia were rescued by re-expression of FLAG-tagged
CDC50A or ATP11A, respectively (Fig. 1e, f and Supplementary
Figure 3a–c). Importantly, ATP11C (a P4-ATPase localized to the
plasma membrane like ATP11A) prevented the morphological
abnormalities seen in the ATP11A-deﬁcient C2C12 syncytia, but
ATP11B residing in intracellular membranes did not (Fig. 1e, f
and Supplementary Figure 3a–c).
We analyzed the inward translocation activity of PS at the
plasma membrane using the ﬂuorescence-labelled PS analogue
NBD-PS8, 20. After incubation of cells for various amounts of time
with NBD-PS, we removed the ﬂuorescent lipid remaining in the
outer leaﬂet by washing with lipid-free bovine serum albumin
(BSA). Flow cytometric analysis of cells incorporating NBD-PS
into the inner leaﬂet showed that PS translocation was
signiﬁcantly reduced in both CDC50A-deﬁcient and ATP11A-
deﬁcient C2C12 cells (Fig. 1g). Flow cytometric analysis of PS-
exposing cells labelled with the PS-binding protein annexin V8
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(Fig. 1h), ﬂuorescent spectroscopic analysis using the surface
charge-sensitive probe F2N12S29 (Supplementary Figure 1h) and
quantiﬁcation of PS contents by thin-layer chromatography
(Supplementary Figure 1i) demonstrated that PS was exposed on
the cell surface in CDC50A-deﬁcient and ATP11A-deﬁcient cells,
without changes in PS content. Although previous studies9, 12–15
have shown that PS is transiently exposed on the cell surface
during myotube formation, the molecular mechanisms under-
lying PS exposure remain unclear. In relation to this event,
caspases are transiently activated in the early phase of myotube
formation30, 31. Although caspase-mediated degradation of
ATP11A has been shown to be responsible for PS exposure
during apoptosis16, it remains unclear whether ATP11A degrada-
tion is involved in PS exposure during myotube formation. Here
we found that ATP11A expression was signiﬁcantly reduced in
the early phase of C2C12 cell differentiation and restored by the
presence of a caspase inhibitor, suggesting that the caspase-
mediated transient cleavage of ATP11A is responsible for PS
exposure on the cell surface (Supplementary Figure 1j). Taken
together, these results suggest that the clearance of cell surface-
exposed PS by the phospholipid ﬂippase complex of ATP11A and
CDC50A (PS ﬂippase) plays a crucial role in the myotube
formation. During myotube formation, assemblies of F-actin and
non-muscle myosin IIA (NMIIA) create actomyosin ﬁbers
underneath the plasma membrane, which prevents uncontrolled
fusion of adjacent myotubes and generates a lateral compression
force to support polarized elongation10, 32. Both F-actin and
NMIIA were enriched at the lateral cortex of wild-type (WT)
C2C12 myotubes, but neither signiﬁcant accumulation of F-actin
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syncytium of the CDC50A-deﬁcient and ATP11A-deﬁcient cells
(Fig. 1i). Analysis of actomyosin localization by quantifying
cortex/cytoplasm ratios33 clearly demonstrated the suppressed
assembly of cortical F-actin and NMIIA in the sheet-like
syncytium, which accumulated in unfused mononuclear cells
(Fig. 1i, j).
PIEZO1 is required for myotube formation. Myotube forma-
tion and the accompanying cortical actomyosin assembly are
dependent on the inﬂux of Ca2+ across the plasma membrane11.
Because mechanical tension is crucial for myoblast fusion
events34, we examined the effect of the depletion of mechan-
osensitive Ca2+-permeable channels expressed in C2C12 myo-
blasts on myotube formation (Supplementary Figure 4a). Of the
Ca2+ channels examined, siRNA-mediated depletion of
PIEZO124, 25, a mechanosensitive Ca2+ channel predominantly
expressed during myotube formation, resulted in the formation of
sheet-like syncytia (Supplementary Figure 4a, b), showing a
morphological phenotype quite similar to that observed in the
ATP11A-deﬁcient and CDC50A-deﬁcient cells (Fig. 1a). Thus, we
established PIEZO1-deﬁcient C2C12 cells using the CRISPR/
Cas9 system28 (Supplementary Figure 4c), in which the mutations
completely abolished the function of PIEZO1 as a Ca2+ channel
(Supplementary Figure 4d–f). Quantitative analyses of syncytium
morphology (Fig. 2a, b and Supplementary Figure 4g, h) and
time-lapse observations (Supplementary Movie 4) conﬁrmed
excessive cell fusion and the cell-elongation defect in PIEZO1-
deﬁcient C2C12 cells. siRNA-mediated depletion of PIEZO1 in
human primary myoblasts also caused morphological abnorm-
alities in myotube formation similar to those observed in PS
ﬂippase-deﬁcient cells (Fig. 2c, d and Supplementary
Figure 2a–c). Moreover, there was no signiﬁcant accumulation of
cortical F-actin or NMIIA in the syncytium formed by the
PIEZO1-deﬁcient C2C12 cells (Fig. 2e, f). These results suggest
that both PS ﬂippase and PIEZO1 are involved in the cortical
actomyosin assembly, as well as in myotube formation.
PS ﬂippase is required for PIEZO1 activation. To eliminate the
possible effect of defective PS ﬂippase expression on translocation
of PIEZO1 to the cell surface, we examined the cellular locali-
zation of PIEZO1 in ﬂippase-deﬁcient C2C12 cells. Both ATP11A
and PIEZO1 were predominantly localized on the plasma mem-
brane (Fig. 2g), and deﬁciency of CDC50A or ATP11A had no
signiﬁcant effect on the cell surface localization of PIEZO1
(Fig. 2h). Next, PIEZO1-mediated Ca2+ inﬂux was monitored by
Fura2 ratiometric imaging using the PIEZO1 activator Yoda1,
which mimics mechanical activation35, 36. Ca2+ inﬂux in
response to Yoda1 was completely abolished in the CDC50A-
deﬁcient C2C12 cells and signiﬁcantly reduced in the ATP11A-
deﬁcient cells (Fig. 3a). The inhibitory effect on PIEZO1 activa-
tion was also observed in human primary myoblasts transfected
with siRNA against CDC50A or ATP11A (Fig. 3b). PIEZO1-
mediated Ca2+ inﬂux in the CDC50A-deﬁcient or ATP11A-
deﬁcient C2C12 cells was recovered by exogenous expression of
CDC50A or one of the PS ﬂippases (i.e., ATP11A or ATP11C8),
respectively (Fig. 3c and Supplementary Figure 5a). PIEZO1
overexpression restored the Yoda1-elicited Ca2+ inﬂux in the
PIEZO1-deﬁcient C2C12 cells, but not in the CDC50A-deﬁcient
cells (Supplementary Figure 5b).
Because lateral membrane tension is the physical stimulus that
activates PIEZO137, we next examined whether depletion of PS
ﬂippase might affect plasma membrane tension. Membrane
tension was measured by pulling a thin tube of membrane from
the cell surface with an adhesive polystyrene bead in an optical
trap38 (Fig. 3d). No signiﬁcant change was observed between WT
and CDC50A-deﬁcient C2C12 cells (Fig. 3e and Supplementary
Figure 5c). In contrast, inhibition of actin polymerization by
treatment with cytochalasin D signiﬁcantly reduced membrane
tension, as previously reported38 (Fig. 3e and Supplementary
Figure 5c). These results raise the intriguing possibility that the
diminished response of PIEZO1 in PS ﬂippase-deﬁcient cells is
due to the change in the transbilayer distribution of PS at the
plasma membrane (Fig. 3f).
Cell surface ﬂip-ﬂop of PS regulates PIEZO1 activity. Next, we
investigated the possible inhibitory effect of cell-surface-exposed
PS on PIEZO1 activation in the course of myotube formation.
Consistent with the results obtained from mouse differentiating
myoblasts9, 12–15, cell surface exposure of PS was clearly observed
on viable human primary myoblasts, accounting for about 20% of
differentiating myoblasts (Fig. 4a). In PS-exposing myoblasts,
PIEZO1-mediated Ca2+ inﬂux was strikingly impaired
(Fig. 4b–d), whereas both the basal Ca2+ concentration and
ionomycin-induced Ca2+ inﬂux were normal (Fig. 4c, e). To
assess whether inward translocation of PS at the plasma mem-
brane is a prerequisite for PIEZO1 activation, the transbilayer
distribution of PS was manipulated by co-expression of PIEZO1
with a constitutively active form of TMEM16F (CA-TMEM16F),
a phospholipid scramblase that induces cell-surface exposure of
PS by bidirectional transport of phospholipids between the
bilayer leaﬂets7, 39 (Fig. 5a). Ca2+ inﬂux via PIEZO1 was
Fig. 1 Defective myotube formation by CDC50A-deﬁcient and ATP11A-deﬁcient myoblasts. a–d Aberrant morphologies of PS ﬂippase-deﬁcient myotubes.
a Syncytia formed by WT and CDC50A-deﬁcient or ATP11A-deﬁcient C2C12 myoblasts were visualized by immunoﬂuorescent staining with anti-MyHC
antibody (differentiated cells, red) and DAPI (nuclei, cyan). b Left: cell fusion evaluated as percentages of syncytia containing ≥50 nuclei in a. Right:
polarized elongation evaluated as percentages of syncytia with aspect ratios ≥3 in a. c Syncytia formed by human primary myoblasts transfected with
control, CDC50A or ATP11A siRNA were visualized by immunoﬂuorescent staining with anti-MyHC antibody and DAPI. d Left: cell fusion evaluated as
percentages of syncytia containing ≥16 nuclei in c. Right: polarized elongation evaluated as percentages of syncytia with aspect ratios ≥3 in c. e, f Rescue of
morphologies in PS ﬂippase-deﬁcient myotubes by overexpression of PS ﬂippase complex components. e Syncytia formed by WT, CDC50A-deﬁcient or
ATP11A-deﬁcient C2C12 myoblasts expressing FLAG-tagged CDC50A, ATP11A, ATP11B or ATP11C were visualized by immunoﬂuorescent staining with
anti-MyHC antibody and DAPI in Supplementary Figure 3b. Left: cell fusion evaluated as percentages of syncytia containing ≥50 nuclei. Right: polarized
elongation evaluated as percentages of syncytia with aspect ratios ≥3. f Localization of FLAG-tagged proteins expressed in CDC50A-deﬁcient or ATP11A-
deﬁcient C2C12 myoblasts. g, h PS exposure on PS ﬂippase-deﬁcient myoblasts. g Flow cytometry analysis of inward translocation (ﬂip) activity of
ﬂuorescence-labelled PS (NBD-PS) at the plasma membrane of WT, CDC50A-deﬁcient and ATP11A-deﬁcient C2C12 myoblasts. h Flow cytometry
histogram of WT, CDC50A- and ATP11A-deﬁcient C2C12 myoblasts labelled with annexin V-GFP. i, j Mislocalization of cortical actomyosin in PS ﬂippase-
deﬁcient myotubes. i Localization of F-actin (phalloidin, red) and NMIIA (anti-NMIIA antibody, green) in WT, CDC50A-deﬁcient and ATP11A-deﬁcient
C2C12 syncytia. Arrows indicate syncytia with diminished peripheral NMIIA accumulation. j Cortex vs. cytoplasm ratio of F-actin and NMIIA signals in i.
****P < 0.0001 (Student’s t-test). NS not signiﬁcant, n sample number. Bar graphs represent mean ± S.E.M. Box and whiskers graph-line: median, box:
upper and lower quartiles, whiskers: maxima and minima. Scale bars: 100 μm (a, c), 20 μm (f, i)
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signiﬁcantly suppressed by the expression of CA-TMEM16F,
compared to that of empty vector-transfected HEK293 cells
(Fig. 5b). In addition, the inhibitory effect of cell-surface PS was
further conﬁrmed by manipulating the cell-surface contents of PS
using the methyl-α-cyclodextrin (MαCD)-catalyzed phospholipid
exchange method40 (Fig. 5c, d). PIEZO1-mediated Ca2+ inﬂux in
CDC50-deﬁcient C2C12 cells was signiﬁcantly recovered when
cell surface-exposed PS was exchanged with exogenous phos-
phatidylcholine (PC), but not with a mixture containing PS (PC/
PS) (Fig. 5e). These results indicate that PS ﬂippase-mediated
inward translocation of cell surface PS, which was exposed during
myotube formation9, 12–15, is essential for PIEZO1 activation.
The direct effect of cell surface-exposed PS was further
examined by treatment with a deacylated form of PS, lyso-
phosphatidylserine (LysoPS), which readily inserts into the outer
leaﬂet of the plasma membrane41 (Fig. 6a, b). Ca2+ inﬂux via
PIEZO1 was dose-dependently suppressed by the incorporation
of LysoPS into the plasma membrane of C2C12 cells, while the
incorporation of a zwitterionic phospholipid, lyso-
phosphatidylcholine (LysoPC), or an anionic phospholipid,
lyso-phosphatidic acid (LysoPA), showed no signiﬁcant inhibi-
tory effect on Ca2+ inﬂux (Fig. 6a, c). Furthermore, slight
modiﬁcation of the serine moiety of LysoPS abolished its ability
to inhibit PIEZO1 activity, suggesting that the stereospeciﬁc
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(Supplementary Figure 5d). Ca2+ inﬂux via PIEZO1 was restored
when LysoPS on the cell surface was removed by washing with
lipid-free BSA8 (Fig. 6d, e). To conﬁrm the inhibitory effect of
LysoPS on membrane tension-induced PIEZO1 activation37, we
conducted electrophysiological measurements of the PIEZO1
current by applying mechanical force to the cell surface using an
electrically-driven glass probe24. In PIEZO1-expressing HEK293
cells, indentation of the cell surface by 8 μm evoked a transient
inward current, consistent with that observed in a previous
study24 (Fig. 6f). The addition of LysoPS signiﬁcantly blunted the
mechanically gated currents, while removal of cell surface-
inserted LysoPS with BSA completely restored the responsiveness
of PIEZO1 to mechanical stimuli (Fig. 6f). No signiﬁcant change
in the current was observed with the addition of LysoPC (Fig. 6g).
In addition, application of negative pressure (−20 mmHg) to the
cell surface evoked a transient inward current in PIEZO1-
expressing cells, and the addition of LysoPS in the recording
pipettes signiﬁcantly blunted the PIEZO1 currents (Supplemen-
tary Figure 5e). These data suggest that the phospholipids with
phosphoserine headgroups present on the outer leaﬂet of the
plasma membrane are responsible for inhibition of PIEZO1
activation.
PS ﬂippase and PIEZO1 regulate cortical actomyosin assembly.
Rho-associated, coiled-coil-containing protein kinase (ROCK) is
a primary effector of RhoA GTPase and induces phosphorylation
of myosin light chain 2 (MLC2) at the Thr-18 and Ser-19 resi-
dues, resulting in NMII activation and subsequent actomyosin
assembly26. The active forms of RhoA and ROCK were co-
localized with F-actin, NMIIA, and MLC2, and partially with
PIEZO1, at the lateral cortex of bipolar C2C12 myoblasts (Sup-
plementary Figure 6a). These observations, together with a pre-
vious report that the RhoA/ROCK pathway is activated by
PIEZO142, suggest that the RhoA/ROCK/actomyosin pathway
plays a dominant role in PS ﬂippase-mediated and PIEZO1-
mediated myotube formation (Fig. 7a). We found that a phos-
phorylated form of MLC2 (P-MLC2) had clearly accumulated at
the lateral cortex of WT myotubes, while no signiﬁcant locali-
zation was observed in the PIEZO1-deﬁcient, CDC50A-deﬁcient
or ATP11A-deﬁcient C2C12 cells (Fig. 7b, c). Stable expression of
a phospho-mimetic form of MLC2 (MLC2-DD: T18D, S19D)
totally prevented aberrant myotube formation in PIEZO1-
deﬁcient C2C12 cells (Fig. 7d, e and Supplementary Figure 6b),
indicating that MLC2 phosphorylation is a downstream event of
PIEZO1 that leads to actomyosin assembly. Furthermore, both
CN03, a selective RhoA activator, and calyculin A, a myosin II
activator that inhibits dephosphorylation of MLC2, prevented the
myotube formation defects observed with CDC50A-deﬁcient,
ATP11A-deﬁcient, and PIEZO1-deﬁcient C2C12 cells (Fig. 7f and
Supplementary Figure 6c, d). These results collectively indicate
that ﬂippase-mediated PS translocation at the plasma membrane
regulates PIEZO1 activation, which promotes RhoA/ROCK-
mediated phosphorylation of MLC2 and subsequent assembly of
cortical actomyosin ﬁbers, thereby controlling fusion and polar-
ized elongation during myotube formation.
A role of ATP11A in muscle regeneration. Since systemic
knockout of Atp11a results in lethality during embryogenesis23,
we generated myoblast-speciﬁc conditional Atp11a-deﬁcient mice
utilizing Myf5-cre transgenic mice that expressed Cre-
recombinase in myoblasts43 (Supplementary Figure 7a) and
examined the muscle phenotype. Primary myoblasts isolated
from the myoblast-speciﬁc Atp11a-deﬁcient mice formed aber-
rantly enlarged syncytia upon differentiation (Fig. 8a, b and
Supplementary Figure 7b), showing the morphological abnorm-
alities observed with ATP11A-deﬁcient myoblasts (Fig. 1a–d).
PIEZO1-mediated Ca2+ inﬂux was also attenuated in the Atp11a-
deﬁcient primary myoblasts (Fig. 8c). However, no obvious
morphological or behavioural abnormalities were observed in
Atp11a-deﬁcient mice by either hematoxylin-eosin staining of
cross/longitudinal muscle sections or functional analyses such as
grip strength and treadmill running tests. To further evaluate the
physiological function of ATP11A and PIEZO1 in myogenesis,
we performed detailed analyses on the stage-speciﬁc and
tissue-speciﬁc expression of ATP11A and PIEZO1 in mouse
muscle tissues. The expression proﬁle of mRNA encoding P4-
ATPases in primary myoblasts isolated from adult skeletal muscle
was quite different from that of adult skeletal muscle: among P4-
ATPases expressed on the plasma membrane16, Atp11a
was a major ﬂippase in primary myoblasts, while strong expres-
sion of Atp8A1, Atp8b2, and Atp11a was observed in adult ske-
letal muscle (Fig. 8d). In developing muscle27, a variety of cell
surface P4-ATPases including Atp8a1, Atp8a2, Atp8b1, Atp8b2,
Atp9a, Atp10d, Atp11a, and Atp11c were expressed16 (Supple-
mentary Figure 7c). These results suggest that these P4-ATPases
may functionally compensate for the defective expression of
ATP11A during developmental myogenesis. Furthermore, no
signiﬁcant expression of PIEZO1 was detected in developing or
adult muscle (Fig. 8e and Supplementary Figure 7c). However, we
did ﬁnd robust expression of PIEZO1 in primary myoblasts as
well as in Pax7-positive satellite cells, a population of myogenic
progenitor cells in adult muscle44 (Fig. 8f, g). The ﬂuorescent
signal of the PIEZO1 antibody in satellite cells was signiﬁcantly
diminished in the presence of the epitope peptide, conﬁrming the
speciﬁcity of the antibody (Fig. 8h). In silico analysis of adult
regenerating myoﬁbres after muscle injury45 showed that
expression levels of Piezo1 as well as Myog (a myogenic marker)
were signiﬁcantly upregulated after induction of muscle injury
Fig. 2 Defective myotube formation by PIEZO1-deﬁcient myoblasts. a–d Aberrant morphologies of PIEZO1-deﬁcient myotubes. a Syncytia formed by WT
and PIEZO1-deﬁcient C2C12 myoblasts were visualized by immunoﬂuorescent staining with anti-MyHC antibody (differentiated cells, red) and DAPI
(nuclei, cyan). b Left: cell fusion evaluated as percentages of syncytia containing ≥50 nuclei in a. Right: polarized elongation evaluated as percentages of
syncytia with aspect ratios ≥3 in a. c Syncytia formed by human primary myoblasts transfected with control or PIEZO1 siRNA were visualized by
immunoﬂuorescent staining with anti-MyHC antibody (differentiated cells, red) and DAPI (nuclei, cyan). d Left: cell fusion evaluated as percentages of
syncytia containing ≥16 nuclei in c. Right: polarized elongation evaluated as percentages of syncytia with aspect ratios ≥3 in c. e, f Mislocalization of
cortical actomyosin in PIEZO1-deﬁcient myotubes. e Localization of F-actin (phalloidin, red) and NMIIA (anti-NMIIA antibody, green) at the cell periphery
of WT and PIEZO1-deﬁcient C2C12 syncytia. Arrows indicate PIEZO1-deﬁcient syncytia with diminished peripheral accumulation of NMIIA. f Cortex vs.
cytoplasm ratio of F-actin and NMIIA signals in e. g, h Normal cell surface expression of PIEZO1 in PS ﬂippase-deﬁcient myoblasts. g Co-localization of
GFP-tagged ATP11A (magenta) and FLAG-tagged PIEZO1 (green) in WT C2C12 myoblasts. Merged images and signal intensities are shown in the bottom
panels. h Co-localization of GFP-tagged PIEZO1 (anti-GFP antibody, green) and F-actin (phalloidin, magenta) at the cell periphery of WT, CDC50A-
deﬁcient and ATP11A-deﬁcient C2C12 myoblasts. Merged images are shown in the bottom panel. ****P < 0.0001 (Student’s t-test). n sample number. Bar
graphs represent mean ± S.E.M. Box and whiskers graph-line: median, box: upper and lower quartiles, whiskers: maxima and minima. Scale bars: 100 μm (a,
c), 20 μm (e), 10 μm (g, h)
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(Supplementary Figure 7d). These observations prompted us to
examine the physiological function of ATP11A in muscle
regeneration.
Adult skeletal muscle has the ability to efﬁciently regenerate
after different types of injury. Muscle regeneration is mediated by
satellite cells residing beneath the basal lamina of muscle ﬁbers,
which are activated after injury and undergo myogenic commit-
ment to become fusion-competent myoblasts44. The resulting
myoblasts fuse with each other to generate nascent syncytia that
mature into functional myoﬁbres10. In this study, we evaluated
the morphology of regenerating myoﬁbres in Atp11a-deﬁcient
tibialis anterior (TA) muscle. Cardiotoxin, a myotoxic agent that
causes degeneration and concomitant regeneration of myoﬁ-
bres46, was injected into TA muscle of Atp11a-deﬁcient mice. The
regenerating muscle tissues were harvested at 2 weeks post-
cardiotoxin injection, then morphological analysis was conducted
by staining longitudinal sections from the cardiotoxin-injected
muscles with anti-laminin antibody (for the extracellular matrix),
anti-MyHC antibody (for myoﬁbres), and DAPI (for nuclei). Our
immunohistological analyses demonstrated that, upon cardio-
toxin administration, abnormal myoﬁbres that fused with each
other were evident in cardiotoxin-injected Atp11a-deﬁcient TA
muscle (Fig. 8i, j), as observed in regenerating muscles of mutant
mice that display the in vitro hyperfusion phenotype47. These
results suggest that ATP11A-mediated PIEZO1 activation plays a
crucial role in proper morphogenesis during myoﬁbre
regeneration.
Discussion
The present study provides evidence that the transbilayer redis-
tribution of PS at the plasma membrane, which is mediated by the
phospholipid ﬂippase complex of ATP11A and CDC50A, plays a
critical role in regulating the Ca2+ channel function of the inte-
gral membrane protein PIEZO1. Recent studies of structural
determination of membrane proteins and molecular simulations
of lipid–protein interactions have demonstrated that the struc-
ture, function, and dynamics of membrane proteins are sig-
niﬁcantly affected by associated lipid molecules48, 49. However, it
remains unclear how lipids act and regulate the function of
membrane proteins in biological membranes, because these
structural and biophysical studies have been conducted in model
systems where membrane proteins are puriﬁed and reconstituted
in artiﬁcial membranes. There is a key difference between artiﬁ-
cial and biological membranes; in biological membranes, phos-
pholipids are asymmetrically distributed between the two leaﬂets
of the bilayer, and are actively transported across the bilayer
leaﬂets by the actions of a family of lipid-transport machineries
such as phospholipid ﬂippase and scramblase.
Phospholipid ﬂippase catalyzes selective translocation of spe-
ciﬁc phospholipid species from the outer to the inner leaﬂet of
cellular membranes, thereby generating the asymmetric transbi-
layer lipid distribution3, 4, 17, 18. A locally unbalanced increase in
the phospholipid number on one side of the membrane drives
bending of the membrane to induce membrane curvature, which
supports recruitment of membrane curvature-sensing proteins in




























































































































































































































































Fig. 3 Impaired PIEZO1 activation in PS ﬂippase-deﬁcient myoblasts. a, b Suppression of agonist-induced PIEZO1 activation by PS ﬂippase deﬁciency. a Left:
Fura2 ratiometric measurements (F340/F380) of Yoda1-induced Ca2+ inﬂux in WT, PIEZO1-deﬁcient, CDC50A-deﬁcient, and ATP11A-deﬁcient C2C12
myoblasts. Right: quantiﬁcation of Yoda1-induced Ca2+ inﬂux as the maximal increment of F340/F380 (Δ ratio) in left. b Left: Fura2 ratiometric
measurements of Yoda1-induced Ca2+ inﬂux in human primary myoblasts transfected with control, PIEZO1, CDC50A or ATP11A siRNA. Right:
quantiﬁcation of Yoda1-induced Ca2+ inﬂux in left. c Rescue of agonist-induced PIEZO1 activation in PS ﬂippase-deﬁcient myoblasts by overexpression of
PS ﬂippase complex components. Quantiﬁcation of Yoda1-induced Ca2+ inﬂux in CDC50A-deﬁcient (left) or ATP11A-deﬁcient (right) C2C12 myoblasts
expressing FLAG-tagged CDC50A, ATP11A, ATP11B or ATP11C. d, e Normal plasma membrane tension in PS ﬂippase-deﬁcient myoblasts. d Schematic
model of membrane tension measurement using an optical trap. e Quantiﬁcation of membrane tension in WT, CDC50A-deﬁcient and cytochalasin D-
treated WT C2C12 cells. f Schematic model showing PS ﬂippase-mediated inward translocation of cell surface-exposed PS as a prerequisite for PIEZO1
activation. **P < 0.01, ***P < 0.001, and ****P < 0.0001 (Student’s t-test). NS not signiﬁcant, n sample number. Box and whiskers graph―line: median,
box: upper and lower quartiles, whiskers: maxima and minima
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vesicle budding within Golgi and endosomal membranes3, 4. In
addition to affecting the curved structure of membranes, phos-
pholipid ﬂippase is thought to regulate the electrostatic properties
of the inner leaﬂet of the plasma membrane3. Phospholipid
ﬂippase-mediated local enrichment of PS in the inner leaﬂet
strengthens the electrostatic interaction between the basic domain
of cytosolic proteins and the membrane, thereby playing a critical
role in the recruitment and activation of various signaling
molecules such as small GTPases and those with pleckstrin
homology domain50, 51. Recent studies have also shown that
lateral reorganization of PS to nanocluster formation drives K-
Ras assembly on the inner leaﬂet via interactions between Ras
basic residues and negatively charged PS50.
Electrostatic interactions of proteins with anionic phospholi-
pids such as PS, phosphatidic acid, and phosphoinositides in the
inner leaﬂet of the plasma membrane50, 52 have been shown to
play a crucial role in controlling the function of membrane-
associated proteins by the so-called ‘electrostatic switch'
mechanism53–57. Based on the results described here, we propose
a lipid-mediated mechanism, namely the ‘ﬂip-ﬂop switch’
mechanism, for tempo-spatial activation of PIEZO1, in which the
regulated change in the transbilayer distribution of particular
lipids, such as PS, regulates the function of the ion channel.
Methods
Reagents. siRNAs and antibodies are summarized in Supplementary Tables 1 and
2, respectively. 1-oleoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-
sn-glycero-3-phosphoserine (18:1-06:0, NBD-PS), 1-oleoyl-2-hydroxy-sn-glycero-
3-phospho-L-serine (18:1, LysoPS), 1-oleoyl-2-hydroxy-sn-glycero-3-
phosphocholine (18:1, LysoPC), 1-oleoyl-2-hydroxy-sn-glycero-3-phosphate (18:1,
LysoPA), 1,2-dioleoyl-sn-glycero-3-phosphocholine (18:1, DOPC) and 1,2-dio-
leoyl-sn-glycero-3-phospho-L-serine (18:1, DOPS) were purchased from Avanti.
LysoPS (18:1) analogues were provided by J.A. and T.O.58, 59.
Plasmids. cDNA clone of human PIEZO1 was purchased from Promega.
MmCdc50a cDNA was obtained from pCMV-Tag4A-CDC50A20. The other mouse
cDNA clones were obtained from mouse (C57BL/6J, Japan SLC Inc.) brain or
C2C12 myoblasts (ATCC). pcDNA3.1-Clover-mRuby2 (#49089), mPIEZO1-IRES-
eGFP (#80925), pX260 (#42229), and pX330 (#42230) were purchased from
Addgene. pGFP-AHD was generated according to previous literature60.
pX330-PGKpuro was generated by inserting a PGK promoter and a puromycin-
resistant gene (from pX260) into pX330. Target sequences were determined using
CRISPRdirect61 (Supplementary Figures 1d and 4c) and introduced into pX330-
PGKpuro. pmClover-N1 and pmClover-C1 were generated by replacing EGFP in
pEGFP-N1 and pEGFP-C1 (Clontech) with mClover (monomeric Clover with
A206K mutation), respectively. pATP11A-mClover and pmClover-NMIIA were
generated by subcloning of ATP11A and NMIIA into pmClover-N1 and
pmClover-C1, respectively. pHsPIEZO1-FLAG was made by subcloning
HsPIEZO1 into pEGFP-N1, followed by replacing EGFP with a FLAG-tag.
pHsPIEZO1-IRES-EGFP was made by inserting HsPIEZO1 into pEGFP-N1,
followed by replacing EGFP with the IRES-EGFP sequence obtained from
pMmPIEZO1-IRES-EGFP. pHsPIEZO1-Clover was generated by subcloning
HsPIEZO1 into pcDNA3.1 (Invitrogen) and inserting Clover at amino acid
position 1591 in PIEZO137. pMmPIEZO1Δ838-849-IRES-EGFP was generated by
switching from the WT to the deleted sequence between the NotI and EcoRI sites of
pMmPIEZO1-IRES-EGFP. Plasmids for full-length ATP11A, truncated ATP11A
(1 bp insertion) and truncated PIEZO1 (13 bp deletion) were generated by
subcloning the corresponding cDNA fragments with a C-terminal FLAG tag into
pIRES2-Venus. pMLC2-WT-mClover-P2A-puro was constructed by subcloning
MLC2 into pEGFP-N1, followed by replacing EGFP with the gene cassette
composed of mClover, a self-cleavage P2A sequence and a puromycin-resistant
gene (from pX260). pMLC2-DD-mClover-P2A-puro was constructed by
introducing phospho-mimetic mutations (T18D/S19D) into pMLC2-WT-
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Fig. 4 Impaired PIEZO1 activation in PS-exposing human primary myoblasts during myotube formation. a Detection of cell surface-exposed PS on
differentiating human primary myoblasts by annexin V-GFP (PS, green), DAPI (nuclei, blue) and ﬁxable viability dye (dead cells, red). b Fura2 imaging of
Ca2+ inﬂux in annexin V-GFP-labelled human primary myoblasts (arrow) upon addition of Yoda1 and ionomycin. Representative traces (c), quantiﬁcation
of Yoda1-induced Ca2+ inﬂux (d) and basal Ca2+ level (e) in b. ****P < 0.0001 (Student’s t-test). NS not signiﬁcant, n sample number. Box and whiskers
graph―line: median, box: upper and lower quartiles, whiskers: maxima and minima. Scale bars: 10 μm (a), 20 μm (b)
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subcloning CDC50A into pCMV-Tag4A (Agilent Technologies) with and without
a stop codon, respectively. pCA-TMEM16F-mRuby2 was generated by subcloning
the cDNA encoding CA-TMEM16F39 into pEGFP-N1 and replacing EGFP with
mRuby2. pEGFP-P4-ATPases and pEGFP-AP3D1 were generated by subcloning
the corresponding full-length into pEGFP-C1. Plasmids of mechanosensitive
channels (pMSCs) were generated by inserting the qPCR-targeting fragment into
pMD-20 (Takara). Retroviral vectors expressing P4-ATPases or CDC50A were
generated by subcloning the corresponding full-length with FLAG- or mClover-tag
at the C-terminus into pMXs-puro (Dr. Toshio Kitamura, the University of
Tokyo). Plasmids were conﬁrmed by sequencing.
Cells. C2C12, HEK293 cells, and human primary myoblasts were purchased from
ATCC, RIKEN BRC and Thermo, respectively. Plat-E cells were a gift from Dr.
Toshio Kitamura. Cells were grown in 10–20% FBS/DMEM in a 37 °C incubator
with 5% CO2.
For CRISPR/Cas9-mediated gene editing28, C2C12 cells were transfected with
pX330-PGKpuro using ViaFect (Promega) for 1 day and cultured with puromycin
(1–3 μg/mL) for 3–5 days. Survived cells were cloned by limited dilution and
genotyped (Supplementary Figures 1d and 4c). Data about CDC50A-deﬁcient,
ATP11A-deﬁcient, and PIEZO1-deﬁcient C2C12 cells were obtained from the
corresponding clone #1 unless otherwise noted.
For stable lines expressing MLC2, C2C12 cells were transfected with pMLC2-
WT-mClover-P2A-puro or pMLC2-DD-mClover-P2A-puro using CUY21EDITII
electroporator (BEX) and cultured with puromycin. For stable lines expressing P4-
ATPases or CDC50A, Plat-E cells were transfected with the pMXs-puro vectors
using Viafect. Resultant retroviruses were used to infect C2C12 cells. Two days
after infection, the cells were cultured with puromycin.
Myotube formation. C2C12 cells or primary myoblasts conﬂuently grown in 20%
FBS/DMEM were maintained in differentiation media [DMEM containing 2%
horse serum (Gibco)] for the indicated periods. For RNA interference, cells were
transfected twice with siRNA using Lipofectamine RNAiMAX (Thermo) and
maintained in differentiation medium for 3 days. In pharmacological experiments,
cells cultured in differentiation media for 2 days were incubated with calyculin A
(1 nM, Wako) or CN03 (2 μg/mL, Cytoskeleton) for an additional 2 days. Z-VAD-
FMK (50 μM, Peptide institute) was added to cells 1 day before switching to dif-
ferentiation medium and maintained for 4 days.
Four days after differentiation, myotubes were stained with anti-MyHC
antibody (14-6503-82, dilution 1:500, eBioscience) and DAPI (Dojindo), and
visualized with an epiﬂuorescence microscope (Axio-Observer.Z1, Zeiss) with a
10× objective lens. The number of nuclei, cell area and best-ﬁt ellipse aspect ratio
were calculated using ImageJ software. Cell fusion was evaluated as the percentage
of nuclei in multinucleate MyHC+ cells (containing ≥16 nuclei) versus the total
number of nuclei in MyHC+ cells in each microscopic ﬁeld27. Polarized elongation
was evaluated as percentages of the sum area occupied by MyHC+ cells with ≥3
aspect ratios versus the total area of MyHC+ cells in the ﬁeld62, 63. Differentiation
level was evaluated as percentages of nuclei in MyHC+ cells versus the total
number of nuclei in each microscopic ﬁeld27.
RT-PCR. Total RNA was isolated using ISOGEN II (Nippon Gene) and
NucleoSpin RNA (Macherey-Nagel). cDNA was generated with PrimeScript II
RTase (Takara) or ReverTra Ace qPCR RT Master Mix (Toyobo). Semi-qPCR was
performed with EmeraldAmp MAX PCR Master Mix (Takara). qPCR was per-
formed with PowerUp SYBR Green Master Mix (Thermo) using the StepOne
system (Thermo). Copy numbers were determined using standard curves from
pEGFP-P4-ATPases, pMSCs and pEGFP-AP3D1, and compared to Ap3d164.
Relative expression was calculated using the 2−ΔΔCt method. Primers are listed in
Supplementary Tables 3 and 4.
Co-immunoprecipitation and immunoblotting. For co-immunoprecipitation,
HEK293 cells were transfected with pEGFP-P4-ATPases and pCDC50A-FLAG
using X-tremeGENE HP DNA (Roche). Two days after transfection, the cells were
lysed in cold buffer (150 mM NaCl, and 50 mM Tris at pH 7.4 containing 1%
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Fig. 5 Suppression of PIEZO1 activation by cell surface-exposed PS. a, b Suppression of agonist-induced PIEZO1 activation by overexpression of
phospholipid scramblases. a Schematic illustration showing inhibition of PIEZO1 activation by CA-TMEM16-mediated bidirectional translocation of PS in
the plasma membrane. b Representative traces (left) and quantiﬁcation (right) of Yoda1-induced Ca2+ inﬂux in HEK293 cells co-expressing PIEZO1 and
CA-TMEM16F. c–e Rescue of agonist-induced PIEZO1 activation in PS ﬂippase-deﬁcient myoblasts by MαCD-catalyzed replacement of cell surface-
exposed PS with exogenous PC. c Schematic illustration showing restoration of PIEZO1 activation by phospholipid exchange between PC-loaded MαCD and
PS-exposing myoblasts. d, e Flow cytometry histograms of annexin V-GFP labelling (d) and quantiﬁcation of Yoda1-induced Ca2+ inﬂux (e) of CDC50A-
deﬁcient C2C12 myoblasts pre-incubated with no lipid-, PC/PS mixture (3:1)- or PC-loaded MαCD. ****P < 0.0001 (Student’s t-test). NS not signiﬁcant, n
sample number. Box and whiskers graph-line: median, box: upper and lower quartiles, whiskers: maxima and minima
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centrifugation, the supernatants were incubated with anti-FLAG M2 afﬁnity gel
(Sigma) for 30 min on ice. After washing with 0.1% Triton X-100/TBS,
immunoprecipitates were eluted with FLAG peptides (500 μg/mL, Sigma) for 30
min on ice. Resulting supernatants were incubated in SDS sample buffer at 50 °C
for 5 min.
For immunoblotting, proteins were separated by SDS-PAGE and transferred to
polyvinylidene diﬂuoride membrane. The membrane was blocked in TBS
containing 5% skim milk and 0.1% Tween 20, stained with antibodies and
visualized using an enhanced chemiluminescent reagent. Uncropped immunoblots
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Fig. 6 Suppression of PIEZO1 activation by cell surface-inserted LysoPS. a Chemical structures of LysoPS, LysoPA and LysoPC. b–d Suppression of agonist-
induced PIEZO1 activation by cell-surface LysoPS. b Schematic model showing suppression of PIEZO1 activation by insertion of LysoPS to the cell surface. c
Representative traces (left) and quantiﬁcation (right) of Yoda1-induced Ca2+ inﬂux in WT C2C12 myoblasts treated with vehicle, LysoPS, LysoPA or LysoPC.
d Schematic model showing restoration of PIEZO1 activation by removal of cell surface-inserted LysoPS with lipid-free BSA. e Representative traces (left)
and quantiﬁcation (right) of Yoda1-induced Ca2+ inﬂux in WT C2C12 myoblasts treated with LysoPS and washed with lipid-free BSA. f, g Impairment of
mechanical stimulation-induced PIEZO1 activation by cell-surface LysoPS. f Representative traces of the mechanically-activated current evoked by
indentation (8 μm) using a glass probe in PIEZO1-expressing HEK293 cells before (grey, control) and during administration of 5 μM LysoPS (red), followed
by removal of LysoPS with lipid-free BSA (blue). g Relative peak currents induced by mechanical stimulation before (control) and during administration of
vehicle (grey), 5 μM LysoPS (red), and 5 μM LysoPC (blue) in f. *P < 0.05 and ****P < 0.0001 (Student’s t-test). NS not signiﬁcant, n sample number. Bar
graphs represent mean ± S.E.M. Box and whiskers graph―line: median, box: upper and lower quartiles, whiskers: maxima and minima
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Fig. 7 RhoA/ROCK-mediated actomyosin formation via the PS ﬂippase/PIEZO1 pathway required for myotube morphology. a Schematic diagram of the PS
ﬂippase/PIEZO1 axis (black) and activators for the RhoA/ROCK/actomyosin pathway (red). b, c Suppressed cortical accumulation of phosphorylated
MLC2 (P-MLC2) in PS ﬂippase-deﬁcient and PIEZO1-deﬁcient myotubes. b Localization of P-MLC2 (anti-P-MLC2 antibody, green), F-actin (phalloidin,
red), and nuclei (DAPI, cyan) in WT, PIEZO1-deﬁcient, CDC50A-deﬁcient, and ATP11A-deﬁcient C2C12 syncytia. Intense co-localization of P-MLC2 and F-
actin was observed on the cell periphery of WT myotubes. c Cortex vs. cytoplasm ratio of P-MLC2 signals in b. d, e Rescue of myotube formation by stable
expression of a phospho-mimetic form of MLC2 in PIEZO1-deﬁcient C2C12 syncytia. d Syncytia formed by WT and PIEZO1-deﬁcient C2C12 myoblasts
stably expressing WT MLC2 (MLC2-WT-GFP) or phospho-mimetic MLC2 (MLC2-DD-GFP) were visualized by immunoﬂuorescent staining with anti-
MyHC antibody (differentiated cells, red) and DAPI (nuclei, cyan). e Left: cell fusion evaluated as percentages of syncytia containing ≥50 nuclei in d. Right:
polarized elongation evaluated as percentages of syncytia with aspect ratios ≥3 in d. f Rescue of myotube formation by activation of the RhoA/ROCK/
actomyosin pathway in PS ﬂippase- or PIEZO1-deﬁcient C2C12 syncytia. Syncytia formed by WT, PIEZO1-deﬁcient, CDC50A-deﬁcient, and ATP11A-
deﬁcient C2C12 syncytia after treatment with calyculin A (a myosin II activator) or CN03 (a selective RhoA activator) were visualized by
immunoﬂuorescent staining with anti-MyHC antibody and DAPI. Morphologies of the syncytia are shown in Supplementary Figure 6c. Left: cell fusion
evaluated as percentages of syncytia containing ≥50 nuclei. Right: polarized elongation evaluated as percentages of syncytia with aspect ratios ≥3. ****P <
0.0001 (Student’s t-test). NS not signiﬁcant, n sample number. Bar graphs represent mean ± S.E.M. Box and whiskers graph-line: median, box: upper and
lower quartiles, whiskers: maxima and minima. Scale bars: 20 μm (b), 100 μm (d)
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Immunoﬂuorescent analyses. Cells were ﬁxed with 4% paraformaldehyde (PFA)/
PBS, permeabilized in 0.1% Triton X-100/PBS, blocked in 1–2% BSA/PBS and
probed with antibodies. An anti-goat tertiary antibody (A-11055, dilution 1:500,
Thermo) was used to detect P-MLC2. Optical sections in the middle of cells were
obtained using a confocal microscope (LSM710, Zeiss) with a 63× objective lens.
Fluorescence proﬁles were analyzed using Zen software (Zeiss).
To determine PIEZO1 localization, either pHsPIEZO1-Clover or pHsPIEZO1-
FLAG alone, pHsPIEZO1-FLAG together with pGFP-AHD, pMLC2-WT-mClover-
P2A-puro or pmClover-NMIIA (1:1), or pHsPIEZO1-FLAG/pATP11A-mClover/
pCDC50A (1:1:1) were introduced into C2C12 myoblasts by electroporation. Cells
were cultured on μ-Dishes ibiTreat for 1 day and probed with phalloidin-TRITC
(Sigma), anti-FLAG (F1804, dilution 1:500, Sigma), anti-GFP (598, dilution 1:1000,
MBL), and anti-ROCK1 (GTX113266, dilution 1:100, GeneTex) antibodies.
To analyze NMIIA or P-MLC2 localization33, C2C12 cells on μ-Dishes ibiTreat
were placed in differentiation medium for 3 days and stained with phalloidin-
TRITC, DAPI, anti-NMIIA (M8064, dilution 1:50, Sigma), and anti-P-MLC2
(3671, dilution 1:50, CST) antibodies. Cell edges were divided into multiple
rectangles orthogonal to the cell periphery. Within the ﬂuorescence proﬁle in each
rectangle, the peak intensity between 0 and 5 μm from the cell edge and the mean









Control mouse primary myoblasts
a
PIEZO1 PAX7 DAPI Merge



































































































































































































































b c a2 b2 b4 b b d b c
Atp8 Atp9 Atp10 Atp11
4 4 126
44
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04436-w
12 NATURE COMMUNICATIONS |  (2018) 9:2049 | DOI: 10.1038/s41467-018-04436-w |www.nature.com/naturecommunications
cytoplasm ratio was determined as the average of the peak versus the mean
intensity of all rectangles.
Time-lapse imaging. C2C12 cells on μ-Dishes ibiTreat were placed in differ-
entiation medium for 2 days and visualized with an LCV110 incubator microscope
equipped with a 20× objective lens (Olympus). DIC images were captured every 20
min for 2 days.
NBD-PS ﬂipping assay. C2C12 myoblasts were detached by Cell Dissociation
Solution Non-enzymatic 1× (Sigma), harvested by centrifugation and washed
with HBSS (Thermo). After being placed on ice for at least 10 min, the assay
was initiated by incubation with 0.1 μM NBD-PS for the indicated periods at
15 °C. The reaction was terminated by resuspension of the cells in HBSS
containing fatty-acid-free BSA (3 mg/mL, Sigma). Cells (0.5–1 × 104) were
analyzed with a ﬂow cytometer (Cytomics FC 500, Beckman). Median
ﬂuorescence intensities of cell populations were determined using FlowJo
software (Tree Star).
Phospholipid exchange. C2C12 cells trypsinized for annexin V labelling or grown
on coverslips for Ca2+ measurements were incubated in PBS or DMEM containing
4 mM MαCD (2,6-Di-O-methyl-α-cyclodextrin, Wako) and 0.3 mM DOPC or 3:1
(mol:mol) DOPC/DOPS for 20 min at 37 °C40.
Annexin V labelling. For ﬂow cytometry, C2C12 cells were detached, re-
suspended in binding buffer (140 mM NaCl, 2.5 mM CaCl2 and 10 mM HEPES at
pH 7.4) and incubated with annexin V-EGFP (Promokine) at room temperature
(RT) for 5 min. Cells (2–4 × 104) were analyzed with a ﬂow cytometer (Cytomics
FC 500, Beckman). Histograms were drawn using FlowJo. Gating strategies are
shown in Supplementary Figure 8.
For confocal microscopy, human primary myoblasts were differentiated on
μ-Dishes ibiTreat for 2 days. After washing with binding buffer, the cells were
incubated with Fixable Viability Dye eFluor 660 (Thermo) at RT for 15 min. Cells
were treated with annexin V-EGFP at RT for 5 min, ﬁxed with 4% PFA/PBS at RT
for 10 min and stained with DAPI.
For Ca2+ measurements, human primary myoblasts were differentiated on Cell
Desk LF1 (Sumitomo Bakelite) for 2 days, incubated with Fura2-AM (15 μM,
Dojindo) at RT for 30 min, washed with binding buffer and incubated with annexin
V-EGFP at RT for 5 min.
F2N12S measurements. C2C12 cells were detached, suspended in HBSS and
placed on ice for at least 10 min. Then, the cells (0.1−1 × 107 cells/mL) were
incubated with F2N12S (0.1 μM, Thermo) for 5 min at 15 °C. Emission spectra
were recorded at an excitation wavelength of 400 nm using an LS55 Fluorescence
Spectrometer (Perkin Elmer) at RT. Spectra were averaged over three replicates and
corrected for lamp intensity variations and blanks.
Ca2+ measurements. Ca2+ measurements were conducted according to previous
literature65. HEK293 cells were transfected with pMmPIEZO1-IRES-EGFP
and pCA-TMEM16F-mRuby2 using ViaFect. The cells were then seeded onto
poly-L-lysine-coated coverslips at one day post transfection and cultured overnight.
C2C12 cells on poly-L-lysine-coated coverslips were transfected with plasmids
expressing PIEZO1 or ATP11A and cultured overnight. Human primary myoblasts
on poly-L-lysine-coated coverslips were transfected with siRNA and cultured for
2 days. Cells were loaded with Fura2-AM (5 μM) in 10% FBS/DMEM at 37 °C for
40 min and washed with HEPES-buffered saline (HBS)65. The coverslip was placed
in a perfusion chamber mounted on a microscope (Axio-observer Z1) at RT. Time-
lapse images were recorded every 10 s. Transfected cells were identiﬁed by ﬂuor-
escent proteins. Cells were perfused with HBS for 2 min, then the perfusion
solution was replaced with HBS containing Yoda1 (0.3–10 μM, Maybridge or
Tocris) for 8 min. To analyze the effect of lyso-lipids, C2C12 cells were perfused
with HBS containing 1–3 μM lyso-lipid for 5 min, then the perfusion solution
was changed to 1 μM Yoda1/HBS for 8 min. After treatment with 3 μM LysoPS for
5 min, the perfusion solution was changed to HBS containing fatty-acid-free BSA
(5 mg/mL) for 5 min, followed by 1 μM Yoda1/HBS for 8 min. To analyze the effect
of LysoPS analogues, cells were incubated with 3 μM LysoPS analogues for 5 min,
perfused with HBS for 2 min, then the perfusion solution was changed to 1 μM
Yoda1/HBS for 10 min. Ratiometric images (F340/F380) were analyzed with Phy-
siology software (Zeiss). Yoda1-induced Ca2+ inﬂux was quantiﬁed as the differ-
ence in the Fura2 ratio between its maximum value and that at 1 min from imaging
initiation.
Electrophysiology. HEK293T cells were transfected with pMmPIEZO1-IRES-
EGFP using Lipofectamine 2000 (Thermo) and reseeded onto coverslips. Whole-
cell recordings on HEK293T expressing MmPIEZO1 at 24–36 h post-transfection
were conducted according to previous literature24. The internal solution contained
(in mM): 140 CsCl, 5 EGTA, 10 HEPES, pH= 7.4 adjusted with CsOH, and the
standard bath solution contained (in mM): 140 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 10
glucose, and 10 HEPES, pH= 7.4 adjusted with NaOH). The folding potential was
−60 mV and currents were recorded at a whole-cell conﬁguration using Axopatch
200B ampliﬁer (Molecular Devices), ﬁltered at 5 kHz with a low-pass ﬁlter and
digitized with Digidata 1440 A (Axon Instruments). Data were acquired with
pCLAMP 10 (Axon Instruments). Glass pipettes (8250; King Precision Glass Inc.)
had a resistance of 2–4MΩ. Mechanical stimulation was provided by membrane
indentation (8 μm) with a glass pipette for 150 ms. Currents were recorded before
(control) and after administration of 5 μM lyso-phospholipid for 1 min, and after
washing with fatty-acid-free BSA for 1 min.
Cell-attached recordings were carried out according to previous literature66.
Electrophysiological recordings on MmPIEZO1-expressing HEK293 cells at 36–60
h post-transfection were conducted using an EPC10 ampliﬁer and Patchmaster
software (HEKA Elektronik). Data were acquired at 5 kHz and ﬁltered at 2.9 kHz.
Glass pipettes (1.5 OD, 0.85 ID; Sutter Instrument Company) had a resistance
of 1.5–4MΩ. The internal and bath solutions were prepared according to
previous literature66. Pressure was administrated using a syringe while
monitoring the pressure with a manometer. Patches were held at −60 mV and
stimulated with negative pressure for 2 s. LysoPS (3 μM) was added to the
internal solution.
Membrane tension measurements. An optical trap system (MMS-1064–200–2L/
2E/2S, Sigma-koki) with a 1064-nm laser was used to trap cell-attached beads.
A 100× oil objective (UPLSAPO100XO, NA= 1.4, Olympus) mounted on an
inverted microscope (IX71, Olympus) was used to trap beads and visualize cells
and beads in bright ﬁeld. A motorized stage (BIOS-225T, Sigma-koki) controlled
by a custom LabView program (National Instruments) was used to pull cells away
from the stationary laser trap.
Trap stiffness calibration was performed by measuring the position variance
of a trapped bead undergoing Brownian motion—a passive stiffness calibration
based on equipartition theorem, assuming the thermal energy for each degree
of freedom to be kBT/2 (where kB is the Boltzmann constant and T the
absolute temperature). The particle is trapped in a harmonic potential in the
x-direction,
Vx ¼ kx x2
 
=2: ð1Þ
kx is the trap stiffness and 〈x2〉 the position variance of the trapped particle. Using
Fig. 8 A role of ATP11A in morphogenesis during myoﬁbre regeneration. (a, b) a Aberrant morphologies of Atp11a-deﬁcient primary myotubes. Syncytia
formed by control or Atp11a-deﬁcient mouse primary myoblasts were visualized by immunoﬂuorescent staining with anti-MyHC antibody (differentiated
cells, red) and DAPI (nuclei, cyan). b Left: cell fusion evaluated as percentages of syncytia containing ≥26 nuclei in a. Right: polarized elongation evaluated
as percentages of syncytia with aspect ratios ≥3 in a. c Suppression of agonist-induced PIEZO1 activation in Atp11a-deﬁcient mouse primary myoblasts.
Quantiﬁcation of Yoda1-induced Ca2+ inﬂux in control or Atp11a-deﬁcient mouse primary myoblasts. d Semi-quantitative RT-PCR analysis of CDC50 family
members and P4-ATPases in mouse primary myoblasts (upper panels) and adult skeletal muscle (lower panels). Arrowheads denote speciﬁc bands. e
Expression levels of Piezo1 in mouse primary myoblasts and adult skeletal muscle, evaluated by quantitative RT-PCR. Gapdh and 18S rRNA were used as
internal controls. f–h Detection of endogenous PIEZO1 protein in satellite cells. Epiﬂuorescence (f) and confocal (g, h) images of mouse myoﬁbres
visualized by immunoﬂuorescent staining with anti-PIEZO1, anti-PAX7 antibodies and DAPI (nuclei). Speciﬁcity of the anti-PIEZO1 antibody was conﬁrmed
by the decreased ﬂuorescence signal in the sample treated with the epitope peptide (h). Arrows indicate Pax7-positive satellite cells. Dashed lines indicate
the cell periphery of myoﬁbres. i, j Aberrant morphologies of Atp11a-deﬁcient regenerated myoﬁbres after cardiotoxin-induced muscle degeneration. i
Longitudinal sections prepared from control (left) and Atp11a-deﬁcient adult muscle (right) were probed with anti-laminin antibody (green), anti-MyHC
antibody (grey), and DAPI (nuclei, blue). Arrows indicate apparent fusion sites with neighboring myoﬁbres. j Evaluation of fused myoﬁbres in i. ***P < 0.001
and ****P < 0.0001 (Student’s t-test). NS not signiﬁcant, n sample number. Bar graphs represent mean ± S.E.M. Box and whiskers graph-line: median, box:
upper and lower quartiles, whiskers: maxima and minima. Scale bars: 100 μm (a), 50 μm (f, i), 10 μm (g, h)
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the information of the trapped particle coordinates:
kx ¼ kBT= xh i2 ð2Þ
The same applies for ﬂuctuation in the y-axis direction.
Images of a trapped bead were captured at 1000 frames/s for 10 s, with the
exposure time of the CCD camera (Zyla 5.5 cMOS, Andor) set to 1 ms. The center
of mass coordinates of the trapped bead was obtained using ImageJ software.
Variance in the x-axis direction 〈x2〉 was obtained by a Gaussian ﬁt to the
probability distribution of x. This resulted in a spring constant kx= 7.29 ± 0.50
[pN/μm]. We also conﬁrmed that ky was similar to that of kx.
For tether pulling experiments, C2C12 cells on poly-L-lysine-coated glass
bottom dishes (Matsunami) were incubated in 10% FBS/DMEM containing
streptavidin-coated polystyrene beads (1.76 μm diameter, Spherotech) conjugated
with biotinylated concanavalin A (J-OIL MILLS) for 1–2 h at 37 °C. For actin
depolymerization, cells were incubated with cytochalasin D (20 μM, Sigma) for 2 h
and washed with 10% FBS/DMEM. Cell-attached beads were trapped and pulled by
moving the stage at 1 μm/s. Images were captured with a CCD camera (Zyla 5.5
cMOS, Andor) every 10 ms.
To obtain membrane tension, force-extension curves were acquired by
calculating the force F exerted on the trapped bead as
F ¼ kxΔx; ð3Þ
where Δx is the deviation of the trapped bead from its original position. A linear ﬁt
was applied to the ﬁrst linear part of the force-extension curves.
PS content. PS was separated from total lipid by two-dimensional thin-layer
chromatography with the ﬁrst solvent system of chloroform/methanol/acetic acid
(65:25:10, v/v/v) and the second solvent system of chloroform/methanol/formic
acid (65:25:10, v/v/v) on a silica plate and assessed by inorganic phosphate
quantiﬁcation67.
Analysis of Atp11a-deﬁcient mice. Animal care, ethical usage and procedures
were approved by the Animal Care Use and Review Committee of the Department
of Engineering of Kyoto University. A transgenic mouse strain (Atp11atm1a(KOMP)
Wtsi) harboring the ‘knockout-ﬁrst’ conditional cassette68 in the Atp11a gene was
purchased from EMMA. Atp11atm1a(KOMP)Wtsi was crossed with B6-Tg(CAG-
FLPe)36 mice69 to generate Atp11atm1c(KOMP)Wtsi mice. The resultant mice were
further mated with Myf5-cre transgenic mice on a C57BL/6 background43, to
generate myoblast-speciﬁc Atp11a-deﬁcient mice.
Myoblasts were isolated from extensor digitorum longus (EDL) muscles
according to previous literature70. EDL myoﬁbres were ﬁxed with 4% PFA/PBS,
permeabilized in 0.5% Triton X-100/PBS and blocked in 3% BSA/PBS. Samples
were stained with anti-Pax7 and anti-PIEZO1 antibodies in the presence or absence
of PIEZO1 peptide (5 μg/mL, Novus Biologicals) and visualized with a confocal
microscope (LSM-800, Zeiss) or an epiﬂuorescence microscope (Axio-observer Z1).
Cardiotoxin experiments were carried out according to previous literature46.
Fifty microliters of 10 μM cardiotoxin (Sigma or Latoxan) was injected into tibialis
anterior muscle of 8- to 12-week-old mice. The muscle was harvested at 2 weeks
post-injection, and snap-frozen in isopentane cooled with liquid nitrogen.
Longitudinal cryosections (thickness, 7 μm) obtained from the muscle were stained
with anti-MyHC and anti-laminin antibodies and visualized with a microscope
(Axio-observer Z1). In silico analysis on regenerating muscle was conducted by
using NCBI dataset (#GDS4924)45.
Statistics and reproducibility. Representative ﬁgures are shown as data from a
single experiment of multiple experiments or average data from pools across multiple
experiments. Samples in quantitative data indicate microscopic ﬁelds (morphological
analysis), single cells (ﬂow cytometry, localization analysis, Ca2+ imaging, membrane
tension measurement, electrophysiology), cell cultures (RT-PCR, PS quantiﬁcation,
F2N12S measurement) and muscles (in silico analysis). Quantitative data of single-
cell-based or microscopic analyses were derived from pools across multiple experi-
ments. All tests were repeated at least three times. Statistical signiﬁcance was deter-
mined with the paired Student’s t-test. Bar and box-whiskers graphs, sample size (n)
and P values are speciﬁed in the ﬁgure legends. No statistical methods to pre-specify
sample size were used. No randomization was used. No blinding was done.
Data availability. Data supporting the ﬁndings of this manuscript are available
from the corresponding authors upon reasonable request.
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